BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical Research

Antengene Announces Phase I Study of Anti-CD24 Monoclonal Antibody ATG-031

Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading commercial-stage innovative, global biopharmaceutical company dedicated to disco...

September 22, 2023 | News

Merck Enters Two Strategic Collaborations to Strengthen AI-driven Drug Discovery

Partnerships with BenevolentAI and Exscientia to drive accelerated drug discovery with higher probability of success Access to end-to-end AI platform ca...

September 21, 2023 | News

Centre for Ion Beam Applications at NUS designated as IAEA's first Collaborating Centre in Singapore

The Centre for Ion Beam Applications (CIBA), a multidisciplinary research centre at the National University of Singapore (NUS), h...

September 21, 2023 | News

Asieris Pharmaceuticals' APL-1702 Achieves Key Milestone in Cervical HSIL Treatment Trial

Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharma company specializing in discovering, developing and commercializing innovative drugs fo...

September 21, 2023 | News

SomaLogic and Korea’s DNA Link Join Forces to Expand SomaScan® Platform in Asia-Pacific Proteomics Market

SomaLogic Inc., (Nasdaq:SLGC), a leader in data-driven proteomics technology, announced its partnership with DNA Link, an innovator in personalized a...

September 20, 2023 | News

China's NMPA Recommends Priority Review for Cefepime-Taniborbactam in UTI Treatment

"Currently, the clinical challenges from multi-drug resistant infections are severe. The recommendation of priority review by CDE for cefepime-taniborbacta...

September 20, 2023 | News

Caliway Completes Recruitment for CBL-514 Cellulite Treatment Phase 2 Study

The CBL-0201EFP Phase 2-stage 2 study is an open-label trial that will evaluate the efficacy, safety, and tolerability of CBL-514 in treating subjects with...

September 20, 2023 | News

Integrated DNA Technologies and Aldevron Partner to Provide CRISPR Components to Therapy Developers

Leading CRISPR gene editing companies Integrated DNA Technologies and Aldevron inked a new global distribution agreement to...

September 19, 2023 | News

Agilent & NCCS Collaborate to Advance Genomic Profiling in Asian Cancers

The scope of the agreement includes the supply of an Agilent Magnis Next-Generation Sequencing (NGS) Preparation System to help investigate details specifi...

September 19, 2023 | News

MGI Collaborates with National Cancer Centre Singapore for Asian Cancer Genomic Profiling

"We are excited to work with NCCS to uncover the unique molecular genomic composition of cancers prevalent in Asia by providing our DNBSEQ-G400 s...

September 18, 2023 | News

Porton Advanced and BRL Medicine Partner to Fast-Track Gene and Cell Therapy Commercialization

BRL Medicine, with its strong gene editing technology, robust R&D capabilities, and prospective pipelines, has been devoted to the realm of CGT for yea...

September 15, 2023 | News

MGI and Bio-Medical Science Partner to Provide Advanced Sequencing Solutions to South Korea

"This MOU marks a key milestone for the development of genomics in South Korea as we introduce localized, high-quality and cost-effective solutio...

September 14, 2023 | News

Menarini Asia-Pacific and Astellas Sign Exclusive Licensing Deal for Smyraf® in Taiwan and SE Asian Markets

Subject to the terms of the agreement, Astellas will receive total payments of up to €5.5 million including upfront and milestone payments. In additio...

September 13, 2023 | News

IPMG Accelerates Access to Innovative Medicines, Boosts Indonesia's Economy Through Partnerships

The limited availability of new drugs and vaccines is a challenge in presenting new hope for Indonesians for innovative therapeutic options with the latest...

September 12, 2023 | News

Stay Connected